Over the past decade, efforts to reduce unnecessary antibiotic use in the neonatal intensive care unit (NICU) have increased. A new report delivered results of a comprehensive quality improvement run in a level 4 NICU with the goal of decreasing antibiotic use by 20%
The investigators ran that initiative within the context of a multicenter learning collaborative that was focused on reducing the unnecessary use of antibiotics.
The strategies for improvement addressed the gaps seen in the core elements of antibiotic stewardship programs. Outcomes measured included the antibiotic use rate and the percentage of infants who were discharged without any exposure to antibiotics.
At the baseline of the quality initiative, the antibiotic use rate was 27.6% and it decreased to 15.5%, which was a 43% reduction in antibiotic use. The reduction was additionally maintained for >18 months.
The investigators said that changes that had the biggest effect on this decrease included a 36-hour hard stop for antibiotics, a novel guideline for early-onset sepsis evaluation among infants <35 weeks, implementing a sepsis risk calculator, and adopting a 36-hour rule-out period for sepsis evaluation.
During the quality initiative, the percent of infants who were discharged from the hospital without any exposure to antibiotics increased from 15.8% to 35.1%.
Additionally, the perfect of infants ≥ 36 weeks who underwent an evaluation for early-onset sepsis decreased by 42.3% and among infants < 35 weeks, it went down by 26%.
The researchers involved in the quality initiative concluded that it had led to a significant reduction in both antibiotic use and exposure in their neonatal intensive care unit.
They also believe that the comprehensive approach to the quality initiative could be useful to other teams that have a focus on improvement.
This article was originally published on Contemporary Pediatrics.com.
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More